Clinical predictors of worsening heart failure during withdrawal from digoxin therapy

American Heart Journal

Volumn 135, Issue 3, 1998, Pages 389-397

  Adams K F , Jr ^a   Gheorghiade, M ^a   Uretsky, B F ^a   Young, J B ^a   Patterson, J H ^a   Tomasko, L ^a   Packer, M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031941922     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(98)70313-8     Document Type: Article

References (27)

1. W Withering An account of the foxglove and some of its medical uses, with practical remarks on dropsy, and other diseases FA Willus TE Keys Classics of cardiology Vol. 1 1941 Henry Schuman, Dover Publications New York 231 252
2. JB Young Do digitalis glycosides still have a role in congestive heart failure? Cardiol Clin 12 1994 51 61
3. M Gheorghiade BJ Zarowitz Review of randomized trials of digoxin therapy in patients with chronic heart failure Am J Cardiol 69 1992 48G 63G
4. SM Dobbs WI Kenyon RJ Dobbs Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients BMJ 1 1977 749 752
5. JL Fleg SH Gottlieb EG Lakatta Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm Am J Med 73 1982 244 250
6. DC Lee RA Johnson JB Bingham M Leahy RE Dinsmore AH Goroll Heart failure in outpatients. A randomized trial of digoxin versus placebo N Engl J Med 306 1982 699 705
7. AJ Taggart GD Johnston DG McDevitt Digoxin withdrawal after cardiac failure in patients with sinus rhythm J Cardiovasc Pharmacol 5 1983 229 234
8. GH Guyatt MJJ Sullivan EL Fallen H Tihal E Rideout S Halcrow A controlled trial of digoxin in congestive heart failure Am J Cardiol 61 1988 371 375
9. SE Pugh NJ White JK Aronson DG Grahame-Smith JG Bloomfield Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment Br Heart J 61 1989 529 539
10. R DiBianco R Shabetai W Kostuk J Moran RC Schlant R Wright for the Milrinone Multicenter Trial Group A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure N Engl J Med 320 1989 677 683
11. The Captopril-Digoxin Multicenter Research Group Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure JAMA 259 1988 539 544
12. German and Austrian Xamoterol Study Group Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure Lancet 1 1988 489 493
13. BF Uretsky JB Young FE Shahidi LG Yellen MC Harrison MK Jolly Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED Trial J Am Coll Cardiol 22 1993 955 962
14. M Packer M Gheorghiade JB Young PJ Costantini KF Adams RJ Cody for the RADIANCE Study Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors N Engl J Med 329 1993 1 7
15. RE Ward M Gheorghiade JB Young B Uretsky Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failure J Am Coll Cardiol 26 1995 93 101
16. R Garg R Gorlin T Smith S Yusuf for the Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
17. DR Cox Regression models and life-tables J R Stat Soc [B] 34 1972 187 220
18. TE. Lee Nonparametric methods of estimating survival functions Statistical methods for survival data analysis 1980 Lifetime Learning Publications Belmont' [CA] 75 87
19. KJ Carlson D.C-S Lee AH Goroll M Leahy RA. Johnson An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients J Chron Dis 38 1985 733 739
20. M Gheorghiade D Ferguson Digoxin: a neurohormonal modulator in heart failure? Circulation 84 1991 2181 2186
21. DW Ferguson WJ Berg JS Sanders PJ Roach JS Kempf MG Kienzle Sympathoinhibitory responses to digitalis glycosides in heart failure patients Circulation 80 1989 65 77
22. DJ van Veldhuisen AJ Man in't Veld PHJM Dunselman DJA Lok HJM Dohmen JC Poortermans on behalf of the DIMT Study Group Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT) J Am Coll Cardiol 22 1993 1564 1573
23. DA Eisner TW Smith The Na-K pump and its effectors in cardiac muscle 2nd edition HA Fozzard E Haber RB Jennings AM Katz HE Morgan The heart and cardiovascular system 1992 Raven Press New York 863 902
24. M Gheorghiade V Hall JB Lakier S Goldstein Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure J Am Coll Cardiol 13 1989 134 142
25. R Jaeschke AD Oxman GH Guyatt To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis Am J Med 88 1990 279 286
26. GD Johnston DG McDevitt Is maintenance digoxin necessary in patients with sinus rhythm? Lancet 1 1979 567 570
27. M Gheorghiade VB Hall G Jacobsen H Alam H Rosman S Goldstein Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors Circulation 92 1995 1801 1807